News & Meetings

Marker will determine type of tumor in a single image, eliminating the need for a biopsy Today, more than 200,000 cancer patients and persons in

Jubilant Radiopharma and Isotopia Molecular Imaging Enter into a Strategic Partnership to Further Advance the Field of Radiotherapeutics Our latest news Our latest news Yardley,

Isotopia and M.T.T.I signed for the supply of Lu-177 n.c.a Isotopia Molecular Imaging and Molecular Targeting Technologies (M.T.T.I) havesigned a clinical supply agreement for Lu177

18-2-2021 Lu177 is better than cabazitaxel in patients with metastatic castration-resistant prostate cancer. An unblinded, randomized phase 2 trial at 11 centers in Australia. the

ARTMS and Isotopia Molecular Imaging Announce Successful Multi-Curie Labeling of PSMA-11 with Cyclotron Produced 68Ga Utilizing the QUANTM Irradiation SystemTM and Solid Targets Burnaby, Canada

Isotopia begins clinical supply collaboration with Y-mAbs Therapeutics. Isotopia is pleased to announce that it has begun a collaboration with Y-mAbs Therapeutics, Inc , a